Immediate Impact
2 from Science/Nature 56 standout
Citing Papers
The JAK-STAT pathway at 30: Much learned, much more to do
2022 Standout
Enfortumab Vedotin in Previously Treated Advanced Urothelial Carcinoma
2021 Standout
Works of A. Y. Chang being referenced
Dose-escalation study of weekly 1-hour paclitaxel administration in patients with refractory cancer.
1997
Phase II Trial of Acivicin Versus Etoposide-Cisplatin in Non-Small Cell Lung Cancer
1994
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| A. Y. Chang | 723 | 488 | 230 | 39 | 1.2k | |
| Preston D. Steen | 567 | 321 | 255 | 47 | 1.0k | |
| Michael Fanucchi | 752 | 792 | 328 | 32 | 1.4k | |
| Donna E. Levy | 467 | 321 | 252 | 24 | 1.5k | |
| Antoine Yver | 1250 | 412 | 340 | 35 | 1.7k | |
| Wolfgang Schuette | 897 | 973 | 228 | 70 | 1.5k | |
| J F Holland | 651 | 239 | 419 | 47 | 1.3k | |
| Tracy L. Leong | 397 | 440 | 325 | 45 | 1.2k | |
| Diane Savarese | 567 | 516 | 271 | 24 | 1.2k | |
| J Prendiville | 735 | 235 | 369 | 39 | 1.3k | |
| John M. Merrill | 401 | 261 | 240 | 25 | 1.1k |
All Works
Login with ORCID to disown or claim papers
Loading papers...